<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03691168</url>
  </required_header>
  <id_info>
    <org_study_id>Shanghai1stSXD</org_study_id>
    <nct_id>NCT03691168</nct_id>
  </id_info>
  <brief_title>Multi-center Observation of the Natural Course of Inherited Retinal Dystrophies</brief_title>
  <acronym>RID</acronym>
  <official_title>Multi-center Observation of the Natural Course of Inherited Retinal Dystrophies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on a clinical multi-center study of the natural course of inherited retinal dystrophies
      in Chinese population, screening fundus imaging indicators for patients with Chinese
      inherited retinal dystrophies, describing the clinical features of Chinese patients with
      inherited retinal dystrophies, and establishing a diagnosis of hereditary retinal diseases -
      Follow-up norms; establish a network-based multi-center diagnosis and follow-up platform;
      obtain a biological sample library of hereditary retinal diseases mainly in China. The
      research will further improve and enrich the genotype, phenotypic characteristics and natural
      course of Chinese inherited retinal dystrophies, in order to promote the clinical evaluation
      of clinical inherited retinal dystrophies and the standardization of genetic diagnosis. It is
      also the evidence for the best timing for future gene therapy, to obtain the best therapeutic
      effect, and to provide a theoretical basis for achieving precise treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>60 months</time_frame>
    <description>A typical Snellen chart that if frequently used for visual acuity testing</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Inherited Retinal Dystrophies</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with inherited retinal dystrophies
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with IRDs whose mutations have been identified

          2. 4~70 years old

          3. Complete 4 basic examinations of the eye: Corrective vision; fundus photography; OCT;
             ERG

        Exclusion Criteria:

          1. Has participated in other interventional treatment studies;

          2. Patients with severe systemic diseases, mental dysplasia, mental illness;

          3. Unable to accept eye examination patients;

          4. Traumatic retinopathy, retinal inflammatory disease, paraneoplastic retinopathy, drug
             toxicity, and rare diseases such as diffuse unilateral subacute optic retinitis

          5. At the initial visit, the patient's binocular vision is displayed as no light.

          6. Both eyes have a history of internal eye surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoDong Sun, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>huixun Jia, Master</last_name>
    <phone>+86 18017317575</phone>
    <email>jiahuixun@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wenqiu Wang, PHD</last_name>
    <phone>+86 13817062881</phone>
    <email>wangwenqiu@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai General Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>huixun Jia, Master</last_name>
      <phone>+86 18017317575</phone>
      <email>jiahuixun@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Wenqiu Wang, PHD</last_name>
      <phone>+86 13817062881</phone>
      <email>wangwenqiu@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>September 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2018</study_first_posted>
  <last_update_submitted>September 28, 2018</last_update_submitted>
  <last_update_submitted_qc>September 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Xiaodong Sun</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Inherited retinal dystrophies, Gene screen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Dystrophies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

